✦ LIBER ✦

172 Stronthum-89 in the management of metastatic carcinoma of the prostate: Results of a phase II study using both physician — and patient- based assessments

✍ Scribed by H. Quon; E. Chow; K.W. Fung; M.K. Gospodarowicz; M. McLean; C. Catton; P. Warde

Book ID: 119511040
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 114 KB
Volume: 55
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(00)81490-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I/II study of strontium-89 combi

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

✍ Lance C. Pagliaro; Ebrahim S. Delpassand; Dallas Williams; Randall E. Millikan; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium‐89 to patients with androgen independent prostate carcinoma. ## METHODS Patients with androgen‐independent pr

Results of a phase III study evaluating

Results of a phase III study evaluating the use of strontium89 therapy as an adjubant to local external beam radiotherapyy in patients with endocrine resistant metastatic prostate cancer — first results of the trans-Canada study

✍ A.T. Porter; A. McEwan 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effect of the somatostatin analog octreo

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study

✍ Friedlander, Terence W.; Weinberg, Vivian K.; Small, Eric J.; Sharib, Jeremy; Ha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 849 KB